Search results
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 2 hours agoTreating America’s obesity epidemic is turning into big business. Two pharmaceutical companies, Eli ...
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
CNBC· 1 day agoAn injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, Dec. 11,...
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC· 1 day agoThe injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24,...
Eli Lilly and Company (LLY) to Issue Quarterly Dividend of $1.30 on June 10th
ETF DAILY NEWS· 15 hours agoEli Lilly and Company (NYSE:LLY – Get Free Report) announced a quarterly dividend on Monday, May 6th, RTT News reports. Eli ...
Eli Lilly Alzheimer’s drug gets FDA panel date after approval delay
The Hill via AOL· 1 day agoAn outside panel of advisers to the Food and Drug Administration (FDA) will meet next month to...
What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
Benzinga via Yahoo Finance· 1 day agoThe open public hearing portion of the meeting will be conducted virtually. The Phase 3 study...
Eli Lilly sets $1.30 dividend for Q2 2024 By Investing.com
Investing.com· 2 days agoEli Lilly and Company (NYSE:LLY), the global pharmaceutical giant, has announced a second-quarter...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill via AOL· 2 hours agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
Motley Fool via Yahoo Finance· 5 days agoEli Lilly (NYSE: LLY) stock has been a top performer thanks to runaway sales of its...
US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10
Reuters via Yahoo News· 1 day agoFood and Drug Administration's approval last year. Lilly's donanemab was declined accelerated...